Retraction
Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study
Paper Information
Record ID:
38686
Author(s):
Publication Date:
July 15, 2021
Retraction Date:
August 24, 2022
(3.2 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Tropical medicine and Hepatogastroenterology department, Mansoura University, Mansoura, Egypt
- Tropical Medicine and Infectious diseases department, Tanta University, Tanta, Egypt
- Endemic medicine department, Cairo University Hospitals, Cairo, Egypt
- Chest department, Mansoura University, Mansoura, Egypt
- Radiology department, Mansoura University, Mansoura, Egypt
- Medical Biochemistry department, Mansoura University, Mansoura, Egypt
- Anesthesia, Surgical Intensive Care and Pain Medicine Department, Tanta University, Tanta, Egypt
- Medical Research Division, National Research Center, Giza, Egypt
- Chest department, Cairo University Hospitals, Cairo, Egypt
Country:
🇪🇬 EgyptArticle Type:
Publisher:
Taylor and Francis
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1080/14787210.2022.2115244Citations (35)
35
Total Citations12
Post-Retraction(34.3%)
23
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
9
Within 1 year
1
After 2+ years
945
Days since retraction (latest)
Concerns about data integrity of randomized clinical trials from one author in the European Journal of Gastroenterology & Hepatology
Kelly X. Zhou, Gideon Meyerowitz‐Katz, Tim Skern et al. (4 authors)
European Journal of Gastroenterology & Hepatology
Published: Mar 2025
945 days after retraction
Toward an Improved Electrocatalytic Determination of Immunomodulator COVID Medication Baricitinib Using Multiwalled Carbon Nanotube Nickel Hybrid
Enas E. Abbas, Ahmed Salah, Maha A. Hegazy et al. (5 authors)
ACS Applied Bio Materials
Published: May 2024
8 citations
8 citations
638 days after retraction
Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations
Michał Ordak
Current Opinion in Allergy and Clinical Immunology
Published: Jan 2024
4 citations
4 citations
511 days after retraction
Voltammetric determination of daclatasvir dihydrochloride at bimetallic Ag/Co nanoparticles modified carbon paste electrode
Sayed S. Badawy, Yomna M. Ahmed, M. A. Sultan
Microchemical Journal
Published: Apr 2023
8 citations
8 citations
244 days after retraction
Assessment of binding interaction to salmon sperm DNA of two antiviral agents and ecofriendly nanoparticles: comprehensive spectroscopic study
Ahmed Faried Abdel Hakiem, Ahmed M. Kamal El-sagheir, Mohammed E. Draz et al. (5 authors)
BMC Chemistry
Open Access
Published: Apr 2023
4 citations
4 citations
238 days after retraction
Severe COVID-19: Drugs and Clinical Trials
Hazael Ramiro Ceja-Gálvez, Francisco Israel Renteria-Flores, Ferdinando Nicoletti et al. (6 authors)
Journal of Clinical Medicine
Open Access
Published: Apr 2023
2 citations
2 citations
235 days after retraction
Concerns about data integrity of 30 randomized clinical trials from one author.
Kelly X. Zhou, Gideon Meyerowitz‐Katz, Ben W. Mol
Unknown Journal
Open Access
Published: Mar 2023
1 citation
1 citation
213 days after retraction
Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX – REVOLUTIOn trial
Israel Silva Maia, Aline Marcadenti, Viviane Cordeiro Veiga et al. (43 authors)
The Lancet Regional Health - Americas
Open Access
Published: Mar 2023
4 citations
4 citations
196 days after retraction
Retraction of Clinical Trials about the SARS-CoV-2 Infection: An Unaddressed Problem and Its Possible Impact on Coronavirus Disease (COVID)-19 Treatment
Felipe Eduardo Valencise, Camila Vantini Capasso Palamim, Fernando Augusto Lima Marson
International Journal of Environmental Research and Public Health
Open Access
Published: Jan 2023
8 citations
8 citations
148 days after retraction
Current diagnostic and therapeutic approaches for severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) and the role of nanomaterial-based theragnosis in combating the pandemic
Beibei Zhang, Qiulan Wu, Liping Yin et al. (7 authors)
Nanotechnology Reviews
Open Access
Published: Jan 2023
2 citations
2 citations
130 days after retraction
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu et al. (5 authors)
Signal Transduction and Targeted Therapy
Open Access
Published: Dec 2022
88 citations
88 citations
103 days after retraction
Human ACE-2, MCP1 and micro-RNA 146 as Novel Markers for COVID- 19 Affection and Severity
Sherief Abd‐Elsalam, Amal Ahmed Mohamed, A. Abdelghani et al. (13 authors)
Infectious Disorders - Drug Targets
Published: Aug 2022
6 days after retraction
Latest in COVID-19 Vaccine 'Candidates' Race
Manar Atoum, Dalia Abu Zreig, Laith Majed Abu Zreig
Infectious Disorders - Drug Targets
Published: Aug 2022
5 days before retraction
MMP3 in Severe COVID-19: A Biomarker or Therapeutic Target?
Andrea Sikora, Sultan Almuntashiri, Duo Zhang et al. (4 authors)
Infectious Disorders - Drug Targets
Open Access
Published: Jun 2022
3 citations
3 citations
64 days before retraction
Epidemiological Study of COVID-19 in Iran and the World: A Review Study
Nasges Ansari, Samira Shokri, Mohadeseh Pirhadi et al. (5 authors)
Infectious Disorders - Drug Targets
Published: May 2022
2 citations
2 citations
89 days before retraction
Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals
Mohammed A. Medhat, Mohamed El‐Kassas, Haidi Karam-Allah et al. (20 authors)
Arab Journal of Gastroenterology
Open Access
Published: May 2022
10 citations
10 citations
110 days before retraction
‘Convalescent Plasma’- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review
Sumel Ashique, Tahamina Khatun, Garima Sahu et al. (8 authors)
Infectious Disorders - Drug Targets
Published: Apr 2022
1 citation
1 citation
120 days before retraction
The Emergence of Omicron SARS-CoV-2 Variant (B.1.1.529): The Latest Episode in the COVID-19 Pandemic with a Global Riposte
Suman Kumar Ray, Sukhes Mukherjee
Infectious Disorders - Drug Targets
Published: Apr 2022
2 citations
2 citations
121 days before retraction
Epigenetic-related Effects of COVID-19 on Human Cells
Arezoo Faramarzi, Reza Safaralizadeh, Narges Dastmalchi et al. (4 authors)
Infectious Disorders - Drug Targets
Published: Apr 2022
3 citations
3 citations
124 days before retraction
COVID-19 Vaccination, Peltzman Effect and Possible Increase in Highrisk Behaviors: A Growing Concern Related to Risk Compensation and Reduced Compliance to Public Health Protective Measures after Vaccines Rollout
Shahab Falahi, Jasem Mohamadi, Hojjat Sayyadi et al. (8 authors)
Infectious Disorders - Drug Targets
Published: Apr 2022
14 citations
14 citations
126 days before retraction
COVID-19 and Coinfections: A Serious Health Threat Requires Combination of Diagnosis and Therapy
Shahid Nawaz, Maira Saleem
Infectious Disorders - Drug Targets
Published: Apr 2022
1 citation
1 citation
139 days before retraction
Therapeutic Strategies for COVID-19 Patients: An Update
Muhammad Ibrahim Getso, Soudabeh Etemadi, Vahid Raissi et al. (7 authors)
Infectious Disorders - Drug Targets
Published: Mar 2022
154 days before retraction
An Updated Review on Complicated Mechanisms of COVID-19 Pathogenesis and Therapy: Direct Viral Damage, Renin-angiotensin System Dysregulation, Immune System Derangements, and Endothelial Dysfunction
Shahab Falahi, Maryam Maleki, Azra Kenarkoohi
Infectious Disorders - Drug Targets
Published: Mar 2022
5 citations
5 citations
155 days before retraction
The Effects of Increased Glucose Level and Glycolysis on SARS CoV-2 Infection
Mustafa Güzel, Fatma Özlem Zurnacı
Mini-Reviews in Medicinal Chemistry
Published: Mar 2022
4 citations
4 citations
156 days before retraction
Does Methylene Blue Satisfy an Option in COVID-19 ARDS
Sri Hari Tanguturi Yella, Sree Sudha Tanguturi Yella, K S B S Krishna Sasanka et al. (4 authors)
Infectious Disorders - Drug Targets
Published: Mar 2022
2 citations
2 citations
159 days before retraction
Efficacy of Sofosbuvir plus Ledipasvir in Egyptian patients with COVID-19 compared to standard treatment: a randomized controlled trial
Mohamed Abdel‐Salam Elgohary, Eman Medhat Hasan, Amany Ahmad Ibrahim et al. (25 authors)
Journal of Medicine and Life
Open Access
Published: Mar 2022
10 citations
10 citations
176 days before retraction
A Review on the New Indication of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in the Treatment of Coronavirus Disease 2019
Hedyieh Karbasforooshan, Sofia Salari, Hesamoddin Hosseinjani
Infectious Disorders - Drug Targets
Published: Feb 2022
2 citations
2 citations
184 days before retraction
Effect of sofosbuvir-based treatment on clinical outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials
Chi‐Kuei Hsu, Ching-Yi Chen, Wang‐Chun Chen et al. (6 authors)
International Journal of Antimicrobial Agents
Open Access
Published: Feb 2022
14 citations
14 citations
199 days before retraction
The Concept of Repurposing in COVID-19 Infection
Lata Potey, Anshu Chaudhary Dudhe, Dhanashri Tumme et al. (5 authors)
Coronaviruses
Published: Feb 2022
199 days before retraction
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
Charan Thej Reddy Vegivinti, Kirk W. Evanson, Hannah Lyons et al. (22 authors)
BMC Infectious Diseases
Open Access
Published: Jan 2022
101 citations
101 citations
205 days before retraction
Diagnostic Stewardship in Times of COVID-19 Pandemic
Lipika Singhal, Ivneet Kour, Varsha Gupta
Infectious Disorders - Drug Targets
Published: Jan 2022
1 citation
1 citation
208 days before retraction
Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment
Noha Samir Taibe, Maimona A. Kord, Mohamed A. Badawy et al. (5 authors)
Therapeutic Advances in Respiratory Disease
Open Access
Published: Jan 2022
4 citations
4 citations
235 days before retraction
Evaluation of Sovodak (sofosbuvir/daclatasvir) treatment outcome in COVID-19 patients compared with Kaletra (lopinavir/ritonavir); a randomized clinical trial
Mahdi Yadollahzadeh, Mohana Eskandari, Maryam Roham et al. (19 authors)
Immunopathologia Persa
Open Access
Published: Sep 2021
2 citations
2 citations
348 days before retraction
Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID‐19: A randomized controlled trial
Sherif Abbass, Ehab Kamal, Mohsen Salama et al. (21 authors)
Journal of Medical Virology
Open Access
Published: Aug 2021
24 citations
24 citations
378 days before retraction
Post-COVID-19 Syndrome Clinical Manifestations: A Systematic Review
Muhammad Abdel‐Gawad, Mariam Zaghloul, Sherief Abd‐Elsalam et al. (11 authors)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Published: Jun 2021
27 citations
27 citations
449 days before retraction
Quick Stats
Total Citations:
35
Years Since Retraction:
3.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025